Apoptosis Deregulation Influences Chemoresistance to Azaguanine in Human Leukemic Cell Lines

REFERENCES

• Duke RC, Ojcius DM, Young JDE. Cell suicide in health and disease. Sci Am 1996;275(6):80–87.
   PubMed Web of Science ®Google Scholar
• Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456–1462.
   PubMed Web of Science ®Google Scholar
• Tanuma SI. Molecular mechanisms of apoptosis. In: Sluyser M (eds.). Apoptosis in Normal Development and Cancer. Bristol, PA: Taylor and Francis; 1996, 39–59.
   Google Scholar
• Fulda S, Debatin KM. Apoptosis in drug response. Curr Pharmacogenomics 2003;1(1):9–16.
   Google Scholar
• Reed JC. Apoptosis and cancer: strategies for integrating programmed cell death. Semin Hematol 2000;37(4):9–16
   PubMed Web of Science ®Google Scholar
• Gorman A, Samali A, McGowan A, Cotter T. Use of flow cytometry techniques in studying mechanisms of apoptosis in leukemic cells. Cytometry 1997;29:97–105.
   PubMedGoogle Scholar
• Aubry J-P, Blaeccke A, Lecoanet-Henchoz S, Jeannin P, Herbault N, Caron G, Moine V, Bonnefoy J-Y. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry 1999;37:197–204.
   PubMedGoogle Scholar
• Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 1997;27: 1–20.
   PubMedGoogle Scholar
• Koopman G, Reutelingsperger CPM, Kuitjen GAM. Anexina V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84(5):1415–1420.
   PubMed Web of Science ®Google Scholar
• Bartkowiak D, Stephanie H, Heinrich B, Nothdurf WR, Öttinger EM. Comparative analysis of apoptosis in HL60 detected by annexin-V and fluorescein-diacetate. Cytometry 1999;37: 191–196.
   PubMedGoogle Scholar
• Pui C-H, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166–178.
   PubMed Web of Science ®Google Scholar
• Dörthe OH, Ulrich G, Hans JS, Ulrike BG, Norbert J, Peter G, Gritta EJ-S. Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92. Blood 2003;102(8):2736–2740.
   PubMed Web of Science ®Google Scholar
• Colsky J, Meiselas LE, Rosen SJ, Schulman I. Response of patients with leukemia to 8-azaguanine. Blood 1955;10:482–492.
   PubMed Web of Science ®Google Scholar
• Dourado M, Sarmento AB, Vale Pereira S, Alves V, Silva T, Mota Pinto A, Santos Rosa M. CD26/DPPIV expression and 8-azaguanine response in T-acute lymphoblastic leukaemia cell lines in culture. Pathophysiology 2007;14:3–10.
   PubMedGoogle Scholar
• Kolata G. Why do cancer cells resist drugs. Science 1986;231: 220–221.
   PubMed Web of Science ®Google Scholar
• Kartner N, Ling V. Multidrug resistance in cancer. Sci Am 1989:26–33.
   Web of Science ®Google Scholar
• Ramu A, Pollard HB, Rosário LM. Doxorubicin resistance in p388 leukemia—evidence for reduced drug influx. Int J Cancer 1989;44:539–547.
   PubMed Web of Science ®Google Scholar
• Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995;18(4):775–794.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. Febs Lett 1995;358:1–3.
   PubMed Web of Science ®Google Scholar
• McKenna SL, Padua RA. Multidrug resistance in leukaemia. Br J Haematol 1997;96:659–674.
   PubMed Web of Science ®Google Scholar
• Aguila JF, Ramos OC, Vázquez RP. Mecanismos de resistencia a la terapia citotóxica. Sangre 1998;45(5):406–414.
   Google Scholar
• Oberley TD, Schultz JL, Li N, Oberley LW. Antioxidant enzyme levels as a function of growth state in cell culture. Free Radic Biol Med 1995;19(1):53–65.
   PubMed Web of Science ®Google Scholar
• Susuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Radic Biol Med 1997;22(1–2):269–281.
   PubMed Web of Science ®Google Scholar
• Freeman BA, Crapo JD. Biology of disease. Free radicals and tissue injury. Lab Invest 1982;47(5):412–426.
   PubMed Web of Science ®Google Scholar
• Southorn PA, Powis G. Free radicals in medicine. II. Involvement in human disease. Mayo Clin Proc 1988;63:390–408.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 2nd edition. Oxford: Clarendon Press, 1989, 543.
   Google Scholar
• Sinha BK, Mimnaugh EG. Free radical and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors. Free Rad Biol Med 1990;8:567–581.
   PubMed Web of Science ®Google Scholar
• Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 1999;49:91–102.
   PubMed Web of Science ®Google Scholar
• O'Connor JH. Flow cytometry versus fluorescence microscopy. In Fluorescence Microscopy and Fluorescent Probes, J Slavík (ed.). New York: Plenum Press, 1996, 61–66.
   Google Scholar
• Orfao A, Schmitz G, Brando B, Ruiz AA, Basso G, Braylan R, Rothe G, Lacombe F, Lanza F, Papa S, Lucio P, San Miguel JF. Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. Clin Chem 1999;45(10):1708–1717.
   PubMed Web of Science ®Google Scholar
• Durkin WJ, Ghanta VK, Balch CM, Davis DW, Hiramoto RN. A methodological approach to the prediction of anticancer drug effect in humans. Cancer Res 1979;39:402–407.
   PubMed Web of Science ®Google Scholar
• Sarmento Ribeiro AB. Alterações fenotípicas da célula tumoral e a sua relação com a resistência à quimioterapia. PhD thesis, University of Coimbra, Coimbra, 2002.
   Google Scholar
• Nϕrgaard MJ, Hockland P. Biology of multiple drug resistance in acute leukaemia. Int J Hematol 2000;72:290–297.
   PubMed Web of Science ®Google Scholar
• Whitlock JA. Principles and pharmacology of chemotherapy. In Wintrobe's Clinical Hematology, Volume 2, 10th edition. Ed. Lee GR, Foerster J, Lukens J, Paraskevas F, greer JP, Rodgers GM. Philadelphia, 540 PA: Williams & Wilkins, Cap. 82, 1999, 2076–2101.
   Google Scholar
• Ramu A, Glaubiger D, Weintraub H. Differences in lipid composition of doxorubicin-sensitive and resistant P388 cells. Cancer Treat Rep 1984;68(4):637–641.
   PubMedGoogle Scholar
• Dumontet C, Fabianowska-Majewska K, Mantincic D, Bauchu EC, Tigaud I, Gandhi V, Lepoivre M, Peters GJ, Rolland MO, Wyczechowska D, Fang X, Gazzo S, Voorn DA, Vanier-Viornery A, Mackey J. Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562. Br J Haematol 1999;106:78–85.
   PubMed Web of Science ®Google Scholar
• Gillin FD, Roufa DJ, Beadet AL, Caskey CT. 8-Azaguanine resistance in mammalian cells. I. Hypoxanthine-guanine phosphoribosyltransferase. Genetics 1972;72:239–252.
   PubMed Web of Science ®Google Scholar
• Löfgreen C, Hjortsberg L, Blennow M, Lofti K, Paul C, Eriksson S, Albertioni F. Mechanisms of cross-resistance between nucleoside analogues and vincristine or daunorubicine in leukemic cells. Bioch Biophys Res Comm 2004;320:825–832.
   PubMed Web of Science ®Google Scholar
• Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15(1):7–10.
   PubMedGoogle Scholar
• Gardner AM, Xu FH, Fady C, Jacoby FJ, Duffey DC, Tu Y, Lichtenstein A. Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic Biol Med 1997;22(1–2):73–83.
   PubMed Web of Science ®Google Scholar
• Lepoivre M, Fieshi F, Coves J, Thelander L, Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide. Biochem Biophys Res Commun 1991;179(1):442–448.
   PubMed Web of Science ®Google Scholar
• Kwon NS, Stuehr DJ, Nathan CF. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 1991;174:761–767.
   PubMed Web of Science ®Google Scholar
• Takagi K, Isobe Y, Yasukawa K, Okouchi E, Suketa Y. Nitric oxide blocks the cell cycle of mouse macrophage-like cells in the early G2+M phase. FEBS Lett 1994;340:159–162.
   PubMed Web of Science ®Google Scholar
• Bettaïeb A, Plo I, Mas VM, Mary AQ, Levade T, Laurent G, Jaffrézou JP. Daunorubicin- and mitoxantrone-triggered phosphatidylcholine hydrolysis: implication in drug-induced ceramid generation and apoptosis. Mol Pharmacol 1999;55:118–125.
   PubMed Web of Science ®Google Scholar
• Toshiyuki M, Reed JC. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993;81(1):151–157.
   PubMed Web of Science ®Google Scholar
• Labroille G, Dumain P, Lacombe F, Belloc F. Flow cytometric evaluation of Fas expression in relation to response and resistance to anthracyclines in leukemic cells. Cytometry 2000;39: 195–202.
   PubMedGoogle Scholar
• Rivest RS, Irwin D, Mandel HG. Inhibition of initiation of translation in L1210 cells by 8-azaguanine. Biochem Pharmacol 1982;31(15):2505–2511.
   PubMed Web of Science ®Google Scholar
• Jia L, Allen PD, Macey MG, Grahn MF, Newland AC, Kelsey SM. Mitochondrial electron transport chain activity, but not ATP synthesis, is required for drug-induced apoptosis in human leukaemia cells: a possible novel mechanism of regulating drug resistance. Br J Haematol 1997;98:686–698.
   PubMed Web of Science ®Google Scholar
• Tu Y, Xu F-H, Liu J, Vescio R, Berenson J, Fady C, Lichetenstein A. Upregulated expression of Bcl-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide and hydrogen peroxide. Blood 1996;88(5):1805–1812.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Shacter E. Bcl-2 does not protect Burkitt's lymphoma cells from oxidant-induced cell death. Blood 1997;89(12):4480–4492.
   PubMed Web of Science ®Google Scholar
• Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Örd T, Bredesen DE. Bcl-2 inhibition of neutral death: decreased generation of reactive oxygen species. Science 1993;262:1274–1277.
   PubMed Web of Science ®Google Scholar
• Baker AF, Briehl MM, Dorr R, Powis G. Decreased antioxidant defence and increased oxidant stress during dexamethasone-induced apoptosis: bcl-2 prevents the loss of antioxidant enzyme activity. Cell Death Differ 1996;3:207–213.
   PubMed Web of Science ®Google Scholar
• Esposti MD, Hatzinisiriou I, McLennan H, Ralph S. Bcl-2 and mitochondrial oxygen radicals. J Biol Chem 1999;274(42): 29831–29837.
   PubMed Web of Science ®Google Scholar
• Schimmer AD, Hedley DW, Penn ZZLZ, Minden MD. Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view. Blood 2001;98(13):3541–3553.
   PubMed Web of Science ®Google Scholar